Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

Daiichi Sankyo

Status and phase: Completed; Phase 3

Conditions: Hypertension

Treatments: Drug: Olmesartan medoxomil; Drug: Amlodipine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00185133

CS8663-A-U301

Details and patient eligibility

About

This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female patients
• 18 years of age or older (20% equal to or older than 65 years)
• With mild to severe hypertension defined as seated diastolic blood pressure of 95-120 mmHg while off any hypertensive medication

Exclusion criteria

• Patients should not have serious concomitant conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patients

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind